Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3674)
All Articles published online
|
Feb 14, 2006 (publication date) through Feb 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chung YC, Huang JH, Lai CW, Sheng HC, Shih SR, Ho MS, Hu YC. Expression, purification and characterization of enterovirus-71 virus-like particles. World J Gastroenterol 2006; 12(6): 921-927 [PMID: 16521221 DOI: 10.3748/wjg.v12.i6.921] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i6/921.htm |
| Number | Citing Articles |
| 1 |
Hu Dong, Hui-Chen Guo, Shi-Qi Sun. Virus-like particles in picornavirus vaccine development. Applied Microbiology and Biotechnology 2014; 98(10): 4321 doi: 10.1007/s00253-014-5639-1
|
| 2 |
Xi Wang, Ke Dong, Min Long, Fang Lin, Zhaowei Gao, Lin Wang, Zhe Zhang, Xi Chen, Ying Dai, Huiping Wang, Huizhong Zhang. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71. Archives of Virology 2018; 163(7): 1851 doi: 10.1007/s00705-018-3797-7
|
| 3 |
Chia-Chyi Liu, Chyi-Sing Hwang, Wun-Syue Yang, Dan-Chin Tsai, Sze-Hsien Wu, Ai-Hsiang Chou, Yen-Hung Chow, Suh-Chin Wu, Jen-Ren Wang, Jen-Ron Chiang, Chin-Cheng Huang, Chien-Hsiung Pan, Pele Chong, Shan Lu. Long-Term Immunogenicity Studies of Formalin-Inactivated Enterovirus 71 Whole-Virion Vaccine in Macaques. PLoS ONE 2014; 9(9): e106756 doi: 10.1371/journal.pone.0106756
|
| 4 |
Shih-Yeh Lin, Li-Yu Sung, Chia-Tsui Yeh, Cheng-Ping Yu, Jyh-Yuan Yang, Yu-Chen Hu. Production and purification of virus-like particles of different enterovirus subtypes as vaccines. Journal of the Taiwan Institute of Chemical Engineers 2018; 82: 1 doi: 10.1016/j.jtice.2017.10.020
|
| 5 |
Ikbel Hadj Hassine, Jawhar Gharbi, Bechr Hamrita, Mohammed A. Almalki, José Francisco Rodríguez, Manel Ben M’hadheb. Characterization of Coxsackievirus B4 virus-like particles VLP produced by the recombinant baculovirus-insect cell system expressing the major capsid protein. Molecular Biology Reports 2020; 47(4): 2835 doi: 10.1007/s11033-020-05333-6
|
| 6 |
Stewart Goodwin, Tobias J. Tuthill, Armando Arias, Richard A. Killington, David J. Rowlands. Foot-and-Mouth Disease Virus Assembly: Processing of Recombinant Capsid Precursor by Exogenous Protease Induces Self-Assembly of Pentamers In Vitro in a Myristoylation-Dependent Manner. Journal of Virology 2009; 83(21): 11275 doi: 10.1128/JVI.01263-09
|
| 7 |
Cheng-Yu Chung, Chi-Yuan Chen, Shih-Yeh Lin, Yao-Chi Chung, Hsin-Yi Chiu, Wei-Kuang Chi, Yu-Li Lin, Bor-Luen Chiang, Wei-Jheng Chen, Yu-Chen Hu. Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield. Vaccine 2010; 28(43): 6951 doi: 10.1016/j.vaccine.2010.08.052
|
| 8 |
Yu-Li Lin, Yu-Chen Hu, Cheng-Chao Liang, Shih-Yeh Lin, Yu-Chih Liang, Hui-Ping Yuan, Bor-Luen Chiang, Cheryl A. Stoddart. Enterovirus-71 Virus-Like Particles Induce the Activation and Maturation of Human Monocyte-Derived Dendritic Cells through TLR4 Signaling. PLoS ONE 2014; 9(10): e111496 doi: 10.1371/journal.pone.0111496
|
| 9 |
A. Roldão, A.C. Silva, M.C.M. Mellado, P.M. Alves, M.J.T. Carrondo. Comprehensive Biotechnology. 2017; : 633 doi: 10.1016/B978-0-12-809633-8.09046-4
|
| 10 |
L. Zhang, N.J. Parham, F. Zhang, M. Aasa-Chapman, E.A. Gould, H. Zhang. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis. Vaccine 2012; 30(13): 2301 doi: 10.1016/j.vaccine.2012.01.061
|
| 11 |
Qunying Mao, Nan Li, Xiang Yu, Xin Yao, Fengxiang Li, Fengmin Lu, Hui Zhuang, Zhenglun Liang, Junzhi Wang. Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71. Archives of Virology 2012; 157(1): 37 doi: 10.1007/s00705-011-1136-3
|
| 12 |
Nikole L. Warner, Jacob Archer, Stephanie Park, Garima Singh, Kathryn M. McFadden, Taishi Kimura, Katrina Nicholes, Adrian Simpson, Jason T. Kaelber, David W. Hawman, Heinz Feldmann, Amit P. Khandhar, Peter Berglund, Matthew R. Vogt, Jesse H. Erasmus. A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical models. Science Translational Medicine 2024; 16(759) doi: 10.1126/scitranslmed.adi1625
|
| 13 |
Jesús Zepeda-Cervantes, Adolfo Cruz-Reséndiz, Alicia Sampieri, Rosalba Carreón-Nápoles, José Iván Sánchez-Betancourt, Luis Vaca. Incorporation of ORF2 from Porcine Circovirus Type 2(PCV2) into genetically encoded nanoparticles as a novel vaccine using a self-aggregating peptide. Vaccine 2019; 37(14): 1928 doi: 10.1016/j.vaccine.2019.02.044
|
| 14 |
Jimmy A Mena, Amine A Kamen. Insect cell technology is a versatile and robust vaccine manufacturing platform. Expert Review of Vaccines 2011; 10(7): 1063 doi: 10.1586/erv.11.24
|
| 15 |
A. Roldão, A.C. Silva, M.C.M. Mellado, P.M. Alves, M.J.T. Carrondo. Comprehensive Biotechnology. 2011; : 625 doi: 10.1016/B978-0-08-088504-9.00072-6
|
| 16 |
Peng-Nien Huang, Shin-Ru Shih. Update on enterovirus 71 infection. Current Opinion in Virology 2014; 5: 98 doi: 10.1016/j.coviro.2014.03.007
|
| 17 |
Natasha Kushnir, Stephen J. Streatfield, Vidadi Yusibov. Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development. Vaccine 2012; 31(1): 58 doi: 10.1016/j.vaccine.2012.10.083
|
| 18 |
Louis Kuijpers, Wouter J. P. van den Braak, Abbas Freydoonian, Nynke H. Dekker, Leo A. van der Pol. Optimization of Enterovirus-like Particle Production and Purification Using Design of Experiments. Pathogens 2025; 14(2): 118 doi: 10.3390/pathogens14020118
|
| 19 |
S. H. Basagoudanavar, M. Hosamani, R. P. Tamil Selvan, B. P. Sreenivasa, P. Saravanan, B. K. Chandrasekhar Sagar, R. Venkataramanan. Development of a liquid-phase blocking ELISA based on foot-and-mouth disease virus empty capsid antigen for seromonitoring vaccinated animals. Archives of Virology 2013; 158(5): 993 doi: 10.1007/s00705-012-1567-5
|
| 20 |
Zeinab Shirbaghaee, Azam Bolhassani. Different applications of virus‐like particles in biology and medicine: Vaccination and delivery systems. Biopolymers 2016; 105(3): 113 doi: 10.1002/bip.22759
|
| 21 |
Dan Yan, Yan-Quan Wei, Hui-Chen Guo, Shi-Qi Sun. The application of virus-like particles as vaccines and biological vehicles. Applied Microbiology and Biotechnology 2015; 99(24): 10415 doi: 10.1007/s00253-015-7000-8
|
| 22 |
Chih-Yeu Fang, Chia-Chyi Liu. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease. Expert Review of Vaccines 2018; 17(9): 819 doi: 10.1080/14760584.2018.1510326
|
| 23 |
L. Pedro, S. S. Soares, G. N. M. Ferreira. Purification of Bionanoparticles. Chemical Engineering & Technology 2008; 31(6): 815 doi: 10.1002/ceat.200800176
|
| 24 |
Chenglei Li, Joseph Che-Yen Wang, Milton W. Taylor, Adam Zlotnick.
In Vitro
Assembly of an Empty Picornavirus Capsid follows a Dodecahedral Path
. Journal of Virology 2012; 86(23): 13062 doi: 10.1128/JVI.01033-12
|
| 25 |
Shih-Yeh Lin, Yao-Chi Chung, Yu-Chen Hu. Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Review of Vaccines 2014; 13(12): 1501 doi: 10.1586/14760584.2014.951637
|
| 26 |
Xiaowen Wang, Xiangqian Xiao, Miao Zhao, Wei Liu, Lin Pang, Xin Sun, Shan Cen, Burton B. Yang, Yuming Huang, Wang Sheng, Yi Zeng. EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge. BMC Research Notes 2016; 9(1) doi: 10.1186/s13104-015-1780-x
|
| 27 |
Hye-Jin Kim, Ho Sun Son, Sang Won Lee, Youngsil Yoon, Ji-Yeon Hyeon, Gyung Tae Chung, June-Woo Lee, Jung Sik Yoo, Florian Krammer. Efficient expression of enterovirus 71 based on virus-like particles vaccine. PLOS ONE 2019; 14(3): e0210477 doi: 10.1371/journal.pone.0210477
|
| 28 |
Zhijian Yang, Fan Gao, Xiaoliang Wang, Likang Shi, Zheng Zhou, Yuanxiang Jiang, Xinxing Ma, Chao Zhang, Chenliang Zhou, Xianfang Zeng, Ge Liu, Jiang Fan, Qunying Mao, Li Shi.
Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in
Pichia pastoris
. Human Vaccines & Immunotherapeutics 2020; 16(7): 1602 doi: 10.1080/21645515.2019.1649554
|
| 29 |
Yangang Pan, Fuxian Zhang, Liuyang Zhang, Shuheng Liu, Mingjun Cai, Yuping Shan, Xianqiao Wang, Hanzhong Wang, Hongda Wang. The Process of Wrapping Virus Revealed by a Force Tracing Technique and Simulations. Advanced Science 2017; 4(9) doi: 10.1002/advs.201600489
|
| 30 |
Mei-Ling Li, Shin-Ru Shih, Blanton S. Tolbert, Gary Brewer. Enterovirus A71 Vaccines. Vaccines 2021; 9(3): 199 doi: 10.3390/vaccines9030199
|
| 31 |
Fabiana Fernandes, Ana P Teixeira, Nuno Carinhas, Manuel JT Carrondo, Paula M Alves. Virus-like Particles in Vaccine Development. 2014; : 120 doi: 10.2217/fmeb2013.13.67
|
| 32 |
Chaoyun Shen, Zhiqiang Ku, Yu Zhou, Dapeng Li, Lili Wang, Ke Lan, Qingwei Liu, Zhong Huang. Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infections. Vaccine 2016; 34(34): 4025 doi: 10.1016/j.vaccine.2016.06.028
|
| 33 |
Zhenglun Liang, Qunying Mao, Qiang Gao, Xiuling Li, Chenghong Dong, Xiang Yu, Xin Yao, Fengxiang Li, Weidong Yin, Qihan Li, Xinliang Shen, Junzhi Wang. Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines. Vaccine 2011; 29(52): 9668 doi: 10.1016/j.vaccine.2011.10.018
|
| 34 |
Stanislav Sokolenko, Steve George, Andreas Wagner, Anup Tuladhar, Jonas M.S. Andrich, Marc G. Aucoin. Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks. Biotechnology Advances 2012; 30(3): 766 doi: 10.1016/j.biotechadv.2012.01.009
|
| 35 |
Young-Joon Ko, Hyang-Sim Lee, Hye-Young Jeoung, Eun-Jeong Heo, Hyo-Rim Ko, Byung-Sik Chang, Hoo-Don Joo, U. Gerelmaa, B. Dashzeveg, S. Tserendorj, R. Sodnomdarjaa, Jong-Hyeon Park, Chang-Hee Kweon, In-Soo Cho, Sang-Gi Paik. Use of a Baculovirus-Expressed Structural Protein for the Detection of Antibodies to Foot-and-Mouth Disease Virus Type A by a Blocking Enzyme-Linked Immunosorbent Assay. Clinical and Vaccine Immunology 2010; 17(1): 194 doi: 10.1128/CVI.00374-09
|
| 36 |
Qin Yan, Linjuan Wu, Longyun Chen, Yali Qin, Zishu Pan, Mingzhou Chen. Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges. Vaccine 2016; 34(35): 4196 doi: 10.1016/j.vaccine.2016.06.058
|
| 37 |
Stacey E. Lynch, James R. Gilkerson, Sally J. Symes, Jin-an Huang, Liliana Tatarczuch, Carol A. Hartley. Equine rhinitis A virus-like particle expressing DNA vaccine induces a virus neutralising immune response in mice. Virus Research 2011; 158(1-2): 294 doi: 10.1016/j.virusres.2011.04.009
|
| 38 |
Jing-Yi Lin, Yu-An Kung, Shin-Ru Shih. Antivirals and vaccines for Enterovirus A71. Journal of Biomedical Science 2019; 26(1) doi: 10.1186/s12929-019-0560-7
|
| 39 |
Yao-Chi Chung, Mei-Shang Ho, Jaw-Chin Wu, Wei-Jheng Chen, Jen-Huang Huang, Szu-Ting Chou, Yu-Chen Hu. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008; 26(15): 1855 doi: 10.1016/j.vaccine.2008.01.058
|
| 40 |
Balaji Somasundaram, Linda HL Lua. Development of picornavirus-like particle vaccines. Pharmaceutical Bioprocessing 2015; 3(1): 45 doi: 10.4155/pbp.14.39
|
| 41 |
Shih-Yeh Lin, Hsin-Yi Chiu, Bor-Luen Chiang, Yu-Chen Hu. Development of EV71 virus-like particle purification processes. Vaccine 2015; 33(44): 5966 doi: 10.1016/j.vaccine.2015.04.077
|
| 42 |
Zhenglun Liang, Qunying Mao, Fan Gao, Junzhi Wang. Progress on the research and development of human enterovirus 71 (EV71) vaccines. Frontiers of Medicine 2013; 7(1): 111 doi: 10.1007/s11684-012-0237-z
|
| 43 |
Shih-Yeh Lin, Yao-Chi Chung, Hsin-Yi Chiu, Wei-Kuang Chi, Bor-Luen Chiang, Yu-Chen Hu. Evaluation of the stability of enterovirus 71 virus-like particle. Journal of Bioscience and Bioengineering 2014; 117(3): 366 doi: 10.1016/j.jbiosc.2013.08.015
|
| 44 |
Yu-Ju Lin, Wen-Ti Liu, Holger Stark, Ching-Tsan Huang. Expression of enterovirus 71 virus-like particles in transgenic enoki (Flammulina velutipes). Applied Microbiology and Biotechnology 2015; 99(16): 6765 doi: 10.1007/s00253-015-6588-z
|
| 45 |
Shih‐Yeh Lin, Chia‐Tsui Yeh, Wan‐Hua Li, Cheng‐Ping Yu, Wen‐Chin Lin, Jyh‐Yuan Yang, Hsueh‐Ling Wu, Yu‐Chen Hu. Enhanced enterovirus 71 virus‐like particle yield from a new baculovirus design. Biotechnology and Bioengineering 2015; 112(10): 2005 doi: 10.1002/bit.25625
|
| 46 |
Prabuddha S. Pathinayake, W. A. Gayan Chathuranga, Hyun-Cheol Lee, Mohammed Y. E. Chowdhury, Moon-Hee Sung, Jong-Soo Lee, Chul-Joong Kim. Inactivated enterovirus 71 with poly-γ-glutamic acid/Chitosan nano particles (PC NPs) induces high cellular and humoral immune responses in BALB/c mice. Archives of Virology 2018; 163(8): 2073 doi: 10.1007/s00705-018-3837-3
|
| 47 |
Kiruthiga Mone, Ninaad Lasrado, Meghna Sur, Jay Reddy. Vaccines against Group B Coxsackieviruses and Their Importance. Vaccines 2023; 11(2): 274 doi: 10.3390/vaccines11020274
|
| 48 |
Wenlong Dai, Chao Zhang, Xueyang Zhang, Pei Xiong, Qingwei Liu, Sitang Gong, Lanlan Geng, Dongming Zhou, Zhong Huang. A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice. Vaccine 2018; 36(5): 653 doi: 10.1016/j.vaccine.2017.12.057
|
| 49 |
Aliyu Maje Bello, Yaowaluck Maprang Roshorm. Recent progress and advances towards developing enterovirus 71 vaccines for effective protection against human hand, foot and mouth disease (HFMD). Biologicals 2022; 79: 1 doi: 10.1016/j.biologicals.2022.08.007
|
| 50 |
Xiaoliang Li, Xizhu Xu, Jichen Li, Huanhuan Lu, Congcong Wang, Rui Wang, Jinbo Xiao, Ying Liu, Yang Song, Jingdong Song, Qiang Sun, Yong Zhang. Preparation and immunoprotective effects of a virus-like particle candidate vaccine of the dominant epidemic D3 genotype coxsackievirus A6 in China. Biosafety and Health 2024; 6(1): 28 doi: 10.1016/j.bsheal.2023.11.001
|
| 51 |
Hao-Yang Li, Jian-Feng Han, Cheng-Feng Qin, Rong Chen. Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. Vaccine 2013; 31(32): 3281 doi: 10.1016/j.vaccine.2013.05.019
|
| 52 |
Qingwei Liu, Xin Tong, Zhong Huang. Towards broadly protective polyvalent vaccines against hand, foot and mouth disease. Microbes and Infection 2015; 17(2): 155 doi: 10.1016/j.micinf.2014.11.004
|
| 53 |
Rui-Yuan Cao, Da-Yong Dong, Rui-Ju Liu, Jian-Feng Han, Guang-Chuan Wang, Hui Zhao, Xiao-Feng Li, Yong-Qiang Deng, Shun-Ya Zhu, Xiao-Yu Wang, Fang Lin, Fu-Jun Zhang, Wei Chen, E-De Qin, Cheng-Feng Qin, Xia Jin. Human IgG Subclasses against Enterovirus Type 71: Neutralization versus Antibody Dependent Enhancement of Infection. PLoS ONE 2013; 8(5): e64024 doi: 10.1371/journal.pone.0064024
|
| 54 |
Roger Fernández, Aida Carreño, Rosa Mendoza, Antoni Benito, Neus Ferrer-Miralles, María Virtudes Céspedes, José Luis Corchero. Escherichia coli as a New Platform for the Fast Production of Vault-like Nanoparticles: An Optimized Protocol. International Journal of Molecular Sciences 2022; 23(24): 15543 doi: 10.3390/ijms232415543
|
| 55 |
D. Zhao, B. Sun, H. Jiang, S. Sun, F.T. Kong, Y. Ma, L. Jiang, L. Bai, X. Chen, P. Yang, C. Liu, Y. Xu, W. Su, W. Kong, F. Xu, C. Jiang. Enterovirus71 virus-like particles produced from insect cells and purified by multistep chromatography elicit strong humoral immune responses in mice. Journal of Applied Microbiology 2015; 119(4): 1196 doi: 10.1111/jam.12922
|
| 56 |
Yu-Li Lin, Chun-I Yu, Yu-Chen Hu, Tze-Jiun Tsai, Yin-Chieh Kuo, Wei-Kuang Chi, Ae-Ning Lin, Bor-Luen Chiang. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles. Vaccine 2012; 30(7): 1305 doi: 10.1016/j.vaccine.2011.12.081
|
| 57 |
Ling Xue, Jiangning Liu, Qi Wang, Chun Zhang, Longfu Xu, Jian Luo, Jian Wang, Chuan Qin, Yongdong Liu, Zhiguo Su. Purification and assembling a fused capsid protein as an enterovirus 71 vaccine candidate from inclusion bodies to pentamer-based nanoparticles. Biochemical Engineering Journal 2017; 117: 139 doi: 10.1016/j.bej.2016.10.009
|
| 58 |
Shiyang Sun, Liping Jiang, Zhenglun Liang, Qunying Mao, Weiheng Su, Huafei Zhang, Xiaojun Li, Jun Jin, Lin Xu, Dandan Zhao, Peihu Fan, Dong An, Ping Yang, Jingcai Lu, Xiuping Lv, Bo Sun, Fei Xu, Wei Kong, Chunlai Jiang. Evaluation of monovalent and bivalent vaccines against lethalEnterovirus71 andCoxsackievirusA16 infection in newborn mice. Human Vaccines & Immunotherapeutics 2014; 10(10): 2885 doi: 10.4161/hv.29823
|
| 59 |
Subrat Kumar Swain, Ayushman Gadnayak, Jatindra Nath Mohanty, Rachita Sarangi, Jayashankar Das. Does enterovirus 71 urge for effective vaccine control strategies? Challenges and current opinion. Reviews in Medical Virology 2022; 32(4) doi: 10.1002/rmv.2322
|
| 60 |
Linda H.L. Lua, Natalie K. Connors, Frank Sainsbury, Yap P. Chuan, Nani Wibowo, Anton P.J. Middelberg. Bioengineering virus‐like particles as vaccines. Biotechnology and Bioengineering 2014; 111(3): 425 doi: 10.1002/bit.25159
|
| 61 |
Fernando Martín, Aida Carreño, Rosa Mendoza, Pablo Caruana, Francisco Rodriguez, Marlon Bravo, Antoni Benito, Neus Ferrer-Miralles, M Virtudes Céspedes, José Luis Corchero. All-in-one biofabrication and loading of recombinant vaults in human cells. Biofabrication 2022; 14(2): 025018 doi: 10.1088/1758-5090/ac584d
|
| 62 |
Zhiqiang Ku, Jinping Shi, Qingwei Liu, Zhong Huang. Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71. Journal of Virological Methods 2012; 186(1-2): 193 doi: 10.1016/j.jviromet.2012.06.025
|
| 63 |
Qianjin Feng, Yaqing He, Jiahai Lu. Virus-Like Particles Produced in Pichia Pastoris Induce Protective Immune Responses Against Coxsackievirus A16 in Mice. Medical Science Monitor 2016; 22: 3370 doi: 10.12659/MSM.900380
|
| 64 |
Amanda Muñoz-Juan, Aida Carreño, Rosa Mendoza, José L. Corchero. Latest Advances in the Development of Eukaryotic Vaults as Targeted Drug Delivery Systems. Pharmaceutics 2019; 11(7): 300 doi: 10.3390/pharmaceutics11070300
|
| 65 |
M. Laura Fabre, Paula N. Arrías, Tomás Masson, Matías L. Pidre, Víctor Romanowski. Emerging and Reemerging Viral Pathogens. 2020; : 197 doi: 10.1016/B978-0-12-814966-9.00011-1
|
| 66 |
Andris Zeltins. Construction and Characterization of Virus-Like Particles: A Review. Molecular Biotechnology 2013; 53(1): 92 doi: 10.1007/s12033-012-9598-4
|
| 67 |
Ke Lyu, Rong Chen. Achievements, challenges and prospects for the development of broadly protective multivalent vaccines and therapeutic antibodies against hand, foot and mouth disease. Science Bulletin 2015; 60(15): 1305 doi: 10.1007/s11434-015-0847-3
|
| 68 |
Hyun-Soo Kim, Hyuk-Jin Moon, Jae-Bang Choi, Beom-Ku Han, Soo Woo. Efficient Production of Enterovirus 71 (EV71) Virus-like Particles by Controlling Promoter Strength in Insect Cells. Viruses 2024; 16(6): 834 doi: 10.3390/v16060834
|
| 69 |
Puxuan Lu, BoPing Zhou. Radiology of Infectious Diseases: Volume 1. 2015; : 127 doi: 10.1007/978-94-017-9882-2_17
|
| 70 |
Hsuen-Wen Chang, Chia-Chyi Liu, Min-Han Lin, Hui-Min Ho, Ya-Ting Yang, Yen-Hung Chow, Pele Chong, Charles Sia. Generation of murine monoclonal antibodies which cross-neutralize human enterovirus genogroup B isolates. Journal of Virological Methods 2011; 173(2): 189 doi: 10.1016/j.jviromet.2011.02.003
|
| 71 |
Fuxiao Liu, Xiaodong Wu, Lin Li, Zengshan Liu, Zhiliang Wang. Use of baculovirus expression system for generation of virus-like particles: Successes and challenges. Protein Expression and Purification 2013; 90(2): 104 doi: 10.1016/j.pep.2013.05.009
|
| 72 |
António Roldão, Maria Candida M Mellado, Leda R Castilho, Manuel JT Carrondo, Paula M Alves. Virus-like particles in vaccine development. Expert Review of Vaccines 2010; 9(10): 1149 doi: 10.1586/erv.10.115
|
| 73 |
Neil David Rawlings, Alan John Barrett, Alex Bateman. Asparagine Peptide Lyases. Journal of Biological Chemistry 2011; 286(44): 38321 doi: 10.1074/jbc.M111.260026
|
| 74 |
Xiaoli Wang, Zhiqiang Ku, Xiang Zhang, Xiaohua Ye, Jinhuan Chen, Qingwei Liu, Wei Zhang, Chao Zhang, Zhenglin Fu, Xia Jin, Yao Cong, Zhong Huang, Julie K. Pfeiffer. Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid. Journal of Virology 2018; 92(1) doi: 10.1128/JVI.01330-17
|
| 75 |
Fabiana Fernandes, Ana P Teixeira, Nuno Carinhas, Manuel JT Carrondo, Paula M Alves. Insect cells as a production platform of complex virus-like particles. Expert Review of Vaccines 2013; 12(2): 225 doi: 10.1586/erv.12.153
|
| 76 |
Minqing Gong, Hongtao Zhu, Jun Zhou, Chunting Yang, Jing Feng, Xiaojun Huang, Gang Ji, Honglin Xu, Ping Zhu, D. S. Lyles. Cryo-Electron Microscopy Study of Insect Cell-Expressed Enterovirus 71 and Coxsackievirus A16 Virus-Like Particles Provides a Structural Basis for Vaccine Development. Journal of Virology 2014; 88(11): 6444 doi: 10.1128/JVI.00200-14
|
| 77 |
Yu-An Kung, Chuan-Tien Hung, Yen-Chin Liu, Shin-Ru Shih. Update on the development of enterovirus 71 vaccines. Expert Opinion on Biological Therapy 2014; 14(10): 1455 doi: 10.1517/14712598.2014.935330
|
| 78 |
Wei Zhang, Wenlong Dai, Chao Zhang, Yu Zhou, Pei Xiong, Shuxia Wang, Xiaohua Ye, Qingwei Liu, Dongming Zhou, Zhong Huang. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity. Emerging Microbes & Infections 2018; 7(1): 1 doi: 10.1038/s41426-018-0094-1
|
| 79 |
Haroldo Cid da Silva Junior, Cristiane Pinheiro Pestana, Ricardo Galler, Marco Alberto Medeiros. Solubility as a limiting factor for expression of hepatitis A virus proteins in insect cell-baculovirus system. Memórias do Instituto Oswaldo Cruz 2016; 111(8): 535 doi: 10.1590/0074-02760160153
|
| 80 |
Yujia Zhai, Danyang Zhang, Leiye Yu, Fang Sun, Fei Sun. SmartBac, a new baculovirus system for large protein complex production. Journal of Structural Biology: X 2019; 1: 100003 doi: 10.1016/j.yjsbx.2019.100003
|
| 81 |
Dandan Zhao, Bo Sun, Shiyang Sun, Bin Fu, Chuntian Liu, Dawei Liu, Yanfei Chu, Youlei Ma, Lu Bai, Yongge Wu, Yan Zhou, Weiheng Su, Ali Hou, Linjun Cai, Fei Xu, Wei Kong, Chunlai Jiang, Yongchang Cao. Characterization of human enterovirus71 virus-like particles used for vaccine antigens. PLOS ONE 2017; 12(7): e0181182 doi: 10.1371/journal.pone.0181182
|
| 82 |
Dingmei Zhang, Jiayuan Lu, Jiahai Lu. Enterovirus 71 vaccine: close but still far. International Journal of Infectious Diseases 2010; 14(9): e739 doi: 10.1016/j.ijid.2009.12.002
|